Neurometrix, Inc.

Last Updated:
Case Status:
Federal Trade Commission, Plaintiff, v. Neurometrix, a Delaware corporation; and Shai Gozani, individually and as an officer of Neurometrix, Inc.; Defendants.
FTC Matter/File Number:

172 3130

Civil Action Number:


Federal Court:
District of Massachusetts

Case Summary

Under a settlement with the Federal Trade Commission announced in March 2020, the marketers of an electrical nerve stimulation device called Quell have agreed to pay $4 million and stop making deceptive claims that the device treats pain throughout the body when placed below the knee. They also will stop claiming the device’s efficacy is clinically proven and that it has been cleared by the FDA to treat pain throughout the body. In early September 2020, the FTC announced it was returning almost $3.9 million to defrauded consumers.